Nutraceuticals market seen topping $835 billion by 2030

The Business Research Company forecasts the global nutraceuticals market will reach $835 billion in 2030, with North America and the U.S. leading the market. The report points to preventive health, aging populations and demand for functional foods as the main growth drivers.

Why it matters: - The nutraceuticals market is projected to become a much larger slice of the pharmaceuticals sector by 2030, reaching nearly one-third of the broader market value. - The forecast points to sustained demand for preventive health products, functional foods and condition-specific nutrition. - The growth outlook signals opportunity across supplements, fortified foods and personalized nutrition products.

What happened: - The Business Research Company released a 2026 nutraceuticals market report with forecasts through 2035. - The report estimates the global nutraceuticals market will surpass $835 billion in 2030. - The market is projected to grow at an 11% compound annual growth rate through 2030. - The broader pharmaceuticals market is expected to reach $2,496 billion by 2030.

The details: - North America is projected to be the largest regional market in 2030 at $327 billion. - North America’s market is expected to rise from $207 billion in 2025, at a 10% CAGR. - The U.S. is forecast to be the largest country market in 2030 at $297 billion. - The U.S. market is expected to grow from $189 billion in 2025, at a 9% CAGR. - Vitamins and minerals are expected to be the largest product type in 2030, accounting for 27% of the market, or $226 billion. - The market is segmented by source into plant, animal and microbial. - The market is segmented by application into functional food, functional beverages, dietary supplements, personal care, animal nutrition and other applications. - The market is segmented by product form into capsules, tablets, softgels, powder, liquid and gummies. - The market is segmented by distribution channel into specialty stores, supermarkets/hypermarkets, convenience stores, drug stores/pharmacies, online retail stores and other channels. - The report says vitamins and minerals, probiotics, proteins and peptides, omega fatty acids and other types together could add more than $335 billion in market value by 2030. - The report projects growth of $91 billion for vitamins and minerals, $82 billion for probiotics, $83 billion for proteins and peptides, $44 billion for omega fatty acids and $35 billion for other types from 2025 to 2030. - The report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, key technologies, future trends, and updated graphics and tables. - The Business Research Company says its research is powered by 1,500,000 datasets, secondary research and interviews with industry leaders. - The company says it has published more than 30,000 reports across 27 industries and 60 geographies. - The report is available as a free sample at the company's sample request page. - The full report is available at the company's market report page.

Between the lines: - The forecast suggests consumers are shifting toward proactive wellness rather than treatment-only nutrition. - Aging populations, health-conscious spending and the rise of functional foods appear to be doing much of the heavy lifting in the growth story. - The strongest categories are concentrated in familiar, mainstream product lines, which could make the market easier to scale through retail and digital channels.

What's next: - The biggest near-term opportunity appears to be in vitamins and minerals, probiotics, proteins and peptides, and omega fatty acids. - The report expects preventive healthcare adoption, healthy aging and fortified foods to keep expanding demand through 2030. - Retail and online distribution will likely remain important as nutraceutical brands broaden access and product formats.